OM:KANBiotechs
We Think Kancera (STO:KAN) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
OM:SOBIBiotechs
Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
OM:HNSABiotechs
Insider Buying: The Hansa Biopharma AB (publ) (STO:HNSA) Senior VP Just Bought kr346k Worth Of Shares
Even if it's not a huge purchase, we think it was good to see that Christian Kjellman, the Senior VP of Hansa Biopharma...
OM:BIOG BBiotechs
Is BioGaia AB (publ)'s (STO:BIOG B) Recent Stock Performance Tethered To Its Strong Fundamentals?
BioGaia (STO:BIOG B) has had a great run on the share market with its stock up by a significant 7.8% over the last...
OM:PROMOBiotechs
Insiders who bought Promore Pharma AB (publ) (STO:PROMO) stock in the last 12 months recover some losses, but still down kr11k
Insiders who purchased kr63k worth of Promore Pharma AB (publ) ( STO:PROMO ) shares over the past year recouped some of...
OM:ISOFOLBiotechs
Shareholders in Isofol Medical (STO:ISOFOL) have lost 38%, as stock drops 11% this past week
For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...
OM:NICABiotechs
Nanologica (STO:NICA) Is Making Moderate Use Of Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
NGM:HAMLET BBiotechs
We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
OM:ACOUBiotechs
AcouSort AB (publ)'s (STO:ACOU) recent kr33m market cap decline means a loss of kr33k for insiders who bought this year
Insiders who acquired kr137k worth of AcouSort AB (publ)'s ( STO:ACOU ) stock at an average price of kr19.11 in the...